Overview

Webcast ImageWebcast
bluebird bio, Inc. Global Update (Replay)
05/19/15 at 8:00 a.m. ET
bluebird bio, Inc. Global Update
Tuesday, May 19, 2015 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile
bluebird bio is a clinical-stage biotechnology company focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy. The company’s mission is to advance the care of patients with life threatening diseases worldwide. Headquartered in Cambridge, Massachusetts, bluebird bio has operations in the U.S. and Europe.
Stock Quote
BLUE (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$178.38
Change (%) Stock is Up 5.44 (3.15%)
Volume994,870
Data as of 05/22/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
05/22/15bluebird bio Announces Participation at the Jefferies 2015 Global Healthcare ConferencePrinter Friendly Version
05/21/15bluebird bio to Present LentiGlobin Clinical Data at 20th Congress of European Hematology AssociationPrinter Friendly Version
05/19/15bluebird bio Announces Global Regulatory Strategy for LentiGlobin BB305 in Beta-Thalassemia MajorPrinter Friendly Version
05/06/15bluebird bio Reports First Quarter 2015 Financial Results and Business UpdatesPrinter Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.